Belluscura Plc engages in the provision of medical devices. The firm focuses on developing oxygen enrichment technology spanning broad industries and therapies. Its oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organizations. The company was founded on December 10, 2015 and is headquartered in London, the United Kingdom.